Yun Oh

1.3k total citations
28 papers, 1.0k citations indexed

About

Yun Oh is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yun Oh has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Yun Oh's work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (9 papers) and Brain Metastases and Treatment (5 papers). Yun Oh is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (9 papers) and Brain Metastases and Treatment (5 papers). Yun Oh collaborates with scholars based in United States, China and South Korea. Yun Oh's co-authors include Roy S. Herbst, Waun Ki Hong, David J. Stewart, Jack A. Roth, Chulso Moon, Li Mao, Larry Lo, Karen Kelly, Philip Bonomi and Jerry L. Klein and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Oncogene.

In The Last Decade

Yun Oh

28 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yun Oh United States	18	561	373	310	137	115	28	1.0k
Yasuji Ishimaru Japan	14	346 0.6×	241 0.6×	204 0.7×	222 1.6×	114 1.0×	45	1.1k
Masafumi Toyoshima Japan	18	494 0.9×	231 0.6×	152 0.5×	145 1.1×	90 0.8×	61	1.1k
Lesley Mathews United States	15	862 1.5×	604 1.6×	253 0.8×	374 2.7×	159 1.4×	21	1.4k
Michael B. Dilling United States	8	876 1.6×	301 0.8×	159 0.5×	143 1.0×	91 0.8×	8	1.1k
Ani Arakelian Canada	21	747 1.3×	361 1.0×	162 0.5×	332 2.4×	101 0.9×	30	1.1k
Markus Grubinger Austria	10	531 0.9×	344 0.9×	134 0.4×	214 1.6×	180 1.6×	12	916
Thorunn Helgason United States	15	467 0.8×	427 1.1×	213 0.7×	342 2.5×	73 0.6×	31	1.1k
Katsumi Koshikawa Japan	16	921 1.6×	675 1.8×	316 1.0×	289 2.1×	70 0.6×	31	1.5k
David Cervi United States	13	554 1.0×	377 1.0×	104 0.3×	226 1.6×	128 1.1×	21	948
Jeonghee Cho South Korea	18	685 1.2×	518 1.4×	422 1.4×	343 2.5×	175 1.5×	31	1.2k

Countries citing papers authored by Yun Oh

Since Specialization

Citations

This map shows the geographic impact of Yun Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun Oh more than expected).

Fields of papers citing papers by Yun Oh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun Oh. The network helps show where Yun Oh may publish in the future.

Co-authorship network of co-authors of Yun Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Yun Oh. A scholar is included among the top collaborators of Yun Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun Oh. Yun Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jänne, Pasi A., Luis Paz‐Ares, Yun Oh, et al.. (2013). Randomized, Double-Blind, Phase II Trial Comparing Gemcitabine-Cisplatin plus the LTB4 Antagonist LY293111 versus Gemcitabine-Cisplatin plus Placebo in First-Line Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(1). 126–131. 28 indexed citations

Hong, David S., Razelle Kurzrock, Yun Oh, et al.. (2011). A Phase 1 Dose Escalation, Pharmacokinetic, and Pharmacodynamic Evaluation of eIF-4E Antisense Oligonucleotide LY2275796 in Patients with Advanced Cancer. Clinical Cancer Research. 17(20). 6582–6591. 113 indexed citations

Tran, Hai T., Ralph Zinner, George R. Blumenschein, et al.. (2010). Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC). Investigational New Drugs. 29(3). 499–505. 17 indexed citations

Oh, Yun, Sarah Taylor, B. Nebiyou Bekele, et al.. (2009). Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases. Cancer. 115(13). 2930–2938. 89 indexed citations

Srivastava, Geetika, Vishal Rana, Sarah Taylor, et al.. (2009). Risk of Intracranial Hemorrhage and Cerebrovascular Accidents in Non-small Cell Lung Cancer Brain Metastasis Patients. Journal of Thoracic Oncology. 4(3). 333–337. 34 indexed citations

Li, Huabin, Weiping Wen, Lei Cheng, et al.. (2008). Expression of Chloride Channel Protein CLC-3 in Patients With Allergic Rhinitis. Archives of Otolaryngology - Head and Neck Surgery. 134(3). 301–301. 8 indexed citations

Greco, F. Anthony, Philip Bonomi, Jeffrey Crawford, et al.. (2008). Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer. Lung Cancer. 61(1). 82–90. 142 indexed citations

Oh, Yun, Roy S. Herbst, Howard A. Burris, et al.. (2008). Enzastaurin, an Oral Serine/Threonine Kinase Inhibitor, As Second- or Third-Line Therapy of Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 26(7). 1135–1141. 54 indexed citations

Akerley, Wallace, John D. Hainsworth, Yun Oh, et al.. (2007). PD3-3-3: Safety of bevacizumab therapy in subjects with brain metastases due to non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 2(8). S467–S467. 7 indexed citations

10.

Xu, Geng, Zhonglin Mou, Hongyan Jiang, et al.. (2007). A Possible Role of CD4⁺CD25⁺ T Cells as Well as Transcription Factor Foxp3 in the Dysregulation of Allergic Rhinitis. The Laryngoscope. 117(5). 876–880. 51 indexed citations

11.

William, William N., Ralph Zinner, Daniel D. Karp, et al.. (2007). Phase I Trial of Motexafin Gadolinium in Combination with Docetaxel and Cisplatin for the Treatment of Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 2(8). 745–750. 22 indexed citations

12.

Xu, Geng, Lei Cheng, Weiping Wen, et al.. (2007). Inverse Association between T‐Cell Immunoglobulin and Mucin Domain‐1 and T‐bet in a Mouse Model of Allergic Rhinitis. The Laryngoscope. 117(6). 960–964. 11 indexed citations

13.

Han, Demin, Bing Zhou, Lei Cheng, Yun Oh, & Hua‐Bin Li. (2006). P38 MAP‐Kinase Pathway Is Involved in the Production of CLC‐3 in Nasal Epithelial Cells With Allergic Rhinitis Induced by Interleukin‐4. The Laryngoscope. 116(11). 1973–1977. 9 indexed citations

14.

Jänne, Pasi A., Luis Paz-Ares Rodríguez, Maya Gottfried, et al.. (2006). Randomized phase II trial of cisplatin/gemcitabine with or without LY293111, a multiple eicosonaid pathway modulator, in patients with chemotherapy naïve advanced non-small cell lung carcinoma. Journal of Clinical Oncology. 24(18_suppl). 7024–7024. 6 indexed citations

15.

Oh, Yun, Imran Mohiuddin, Yan Sun, et al.. (2005). Phenotypic Diversity of the Lung Vasculature in Experimental Models of Metastases. CHEST Journal. 128(6). 596S–600S. 12 indexed citations

16.

Zinner, Ralph, Frank V. Fossella, Gregory W. Gladish, et al.. (2005). Phase II study of pemetrexed in combination with carboplatin in the first‐line treatment of advanced nonsmall cell lung cancer. Cancer. 104(11). 2449–2456. 74 indexed citations

17.

Kwon, Ohsuk, Yun Oh, Min‐Gon Kim, et al.. (2004). Fabrication of a Partial Genome Microarray of the Methylotrophic Yeast Hansenula polymorpha: Optimization and Evaluation of Transcript Profiling. Journal of Microbiology and Biotechnology. 14(6). 1239–1248. 13 indexed citations

18.

Oh, Yun, Román Pérez-Soler, Bonnie S. Glisson, et al.. (2000). Phase II Study of Intravenous Doxil® in Malignant Pleural Mesothelioma. Investigational New Drugs. 18(3). 243–245. 23 indexed citations

19.

Kim, Se K., Li-Kuo Su, Yun Oh, et al.. (1998). Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines. Oncogene. 16(1). 89–93. 54 indexed citations

20.

Oh, Yun, You Hong Fan, Li-Kuo Su, et al.. (1998). TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer. Oncogene. 17(9). 1141–1148. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact